297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

Bibliographic Details
Main Authors:	D Staskin, J Frankel, S Varano, H Greene, E Thomas
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Continence
Online Access:	http://www.sciencedirect.com/science/article/pii/S277297372200652X

Similar Items

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study
by: David Staskin, et al.
Published: (2023-03-01)

Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
by: David Staskin, et al.
Published: (2022-01-01)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
by: Frankel J, et al.
Published: (2022-03-01)

EFFICACY OF VIBEGRON ON URGENCY URINARY INCONTINENCE AND PATIENT-REPORTED QUALITY OF LIFE: SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL
by: D Staskin, et al.
Published: (2023-09-01)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
by: Jeffrey Frankel, et al.
Published: (2023-03-01)

Plain Language Summary of Publication: What is the effect of the medicine vibegron in the treatment of overactive bladder in patients with and without bladder leakage?
by: David Staskin, et al.
Published: (2025-01-01)

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis
by: Michael Kennelly, et al.
Published: (2022-10-01)

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
by: Jung Hyun Shin, et al.
Published: (2023-06-01)

Comment on: update on the management of overactive bladder
by: David Staskin
Published: (2022-01-01)

Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder
by: Roger R. Dmochowski, et al.
Published: (2023-04-01)

Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults?
by: Jennifer King, et al.
Published: (2024-12-01)

3-MONTH INTERIM RESULTS OF A PHASE 4, REAL-WORLD STUDY (COMPOSUR) TO EVALUATE VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER
by: S MacDiarmid, et al.
Published: (2023-09-01)

Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder
by: Yan Hu, et al.
Published: (2024-04-01)

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder
by: Cardozo Linda, et al.
Published: (2010-08-01)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
by: Makhani A, et al.
Published: (2020-04-01)

Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

The overactive bladder
by: Richard Foon, et al.
Published: (2010-08-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report
by: Taiki Kato, et al.
Published: (2021-02-01)

Efficacy and safety of non-invasive low-frequency tibial nerve stimulator in overactive bladder
by: Zhipeng Zhang, et al.
Published: (2025-01-01)

Overactive Bladder in Children
by: Rhaiana Gondim Oliveira, et al.
Published: (2018-06-01)

Overactive bladder in males
by: Alex Gomelsky, et al.
Published: (2009-10-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder
by: Nidhi Sharma, et al.
Published: (2016-10-01)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
by: Sheng-Mou Hsiao, et al.
Published: (2019-03-01)

Urinary incontinence and overactive bladder
by: Chris Heyns
Published: (2002-03-01)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007-03-01)

Over Overactive Bladder (OAB)
by: Bansithi Chayaprasithi
Published: (2007-09-01)

Updates of Overactive Bladder in Pediatrics
by: Jisung Shim, et al.
Published: (2023-03-01)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007-01-01)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018-07-01)

Overactive bladder in the vulnerable elderly
by: Wolff GF, et al.
Published: (2014-10-01)

Review of the epidemiology of overactive bladder
by: Eapen RS, et al.
Published: (2016-06-01)

Mediterranean Diet and Overactive Bladder
by: Yunus Erol Bozkurt, et al.
Published: (2022-06-01)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018-07-01)

Acupuncture for Treatment of Overactive Bladder
by: Maryam Hosseini, et al.
Published: (2021-06-01)

Pharmacologic management of overactive bladder
by: Sum Lam, et al.
Published: (2007-10-01)